Literature DB >> 8169523

Mouse apolipoprotein J: characterization of a gene implicated in atherosclerosis.

T C Jordan-Starck1, S D Lund, D P Witte, B J Aronow, C A Ley, W D Stuart, D K Swertfeger, L R Clayton, S F Sells, B Paigen.   

Abstract

Apolipoprotein J (apoJ), a glycoprotein associated with subclasses of plasma high density lipoproteins (HDL), was found to accumulate in aortic lesions in a human subject with transplantation-associated arteriosclerosis and in mice fed a high-fat atherogenic diet. Foam cells present in mouse aortic valve lesions expressed apoJ mRNA, suggesting local synthesis contributes to apoJ's localization in atherosclerotic plaque. As a prerequisite for elucidating the physiological function of apoJ by using a mouse model, cDNA clones representing the mouse homolog of apoJ were isolated, characterized, and sequenced. The nucleotide sequence predicts a 448 amino acid, 50,260 dalton protein. There was 81% nucleotide sequence similarity between mouse and human apoJ, and 75% similarity at the amino acid level. Mouse apoJ contains six potential N-glycosylation sites, a potential Arg-Ser cleavage site to generate alpha and beta subunits, a cluster of five cysteine residues in each subunit, three putative amphipathic helices, and four potential heparin-binding domains. Southern blot analysis indicates that the gene encompasses approximately 23 kb of DNA. Recombinant inbred strains were used to map apoJ to mouse chromosome 14, tightly linked to Mtv-11. All of the transcribed portions of the gene were cloned and analyzed, and all intron-exon boundaries were defined. The first of the 9 exons is untranslated. Single exons encode the signal peptide, the cysteine-rich domain in the alpha subunit, two potential amphipathic helices flanking a heparin-binding consensus sequence, and a potential amphipathic helix overlapping a heparin-binding domain, supporting their potential functional significance in apoJ. A variety of mouse tissues constitutively express a 1.9 kb apoJ mRNA, with apparently identical transcriptional start sites utilized in all tissues tested. ApoJ mRNA was most abundant in stomach, liver, brain, and testis, with intermediate levels in heart, ovary, and kidney. The high degree of similarity between mouse and human apoJ, in structure and distribution of the gene product, gene structure, and deposition in atherosclerotic plaques, suggests that the mouse is an ideal model with which to elucidate the role of apoJ in HDL metabolism and atherogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8169523

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  17 in total

1.  Clusterin synergizes with IL-2 for the expansion and IFN-γ production of natural killer cells.

Authors:  Chung Hee Sonn; Young-Bin Yu; Young-Joo Hong; Young-Jun Shim; Jeffrey A Bluestone; Bon-Hong Min; Kyung-Mi Lee
Journal:  J Leukoc Biol       Date:  2010-08-20       Impact factor: 4.962

2.  Plasma proteomic profiles of bovine growth hormone transgenic mice as they age.

Authors:  Juan Ding; Darlene E Berryman; John J Kopchick
Journal:  Transgenic Res       Date:  2011-03-02       Impact factor: 2.788

3.  Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.

Authors:  M Navab; S Hama-Levy; B J Van Lenten; G C Fonarow; C J Cardinez; L W Castellani; M L Brennan; A J Lusis; A M Fogelman; B N La Du
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

4.  Identification of human plasma proteins as major clients for the extracellular chaperone clusterin.

Authors:  Amy R Wyatt; Mark R Wilson
Journal:  J Biol Chem       Date:  2009-12-07       Impact factor: 5.157

5.  Functional and structural properties of lipid-associated apolipoprotein J (clusterin).

Authors:  M Calero; T Tokuda; A Rostagno; A Kumar; B Zlokovic; B Frangione; J Ghiso
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

6.  Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer's disease.

Authors:  D J Stone; I Rozovsky; T E Morgan; C P Anderson; C E Finch
Journal:  J Neurosci       Date:  1998-05-01       Impact factor: 6.167

7.  Apolipoprotein J (clusterin) induces cholesterol export from macrophage-foam cells: a potential anti-atherogenic function?

Authors:  I C Gelissen; T Hochgrebe; M R Wilson; S B Easterbrook-Smith; W Jessup; R T Dean; A J Brown
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

8.  Clusterin promotes the aggregation and adhesion of renal porcine epithelial cells.

Authors:  J R Silkensen; K M Skubitz; A P Skubitz; D H Chmielewski; J C Manivel; J A Dvergsten; M E Rosenberg
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

9.  Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis.

Authors:  L McLaughlin; G Zhu; M Mistry; C Ley-Ebert; W D Stuart; C J Florio; P A Groen; S A Witt; T R Kimball; D P Witte; J A Harmony; B J Aronow
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

10.  Proteome Profiling of Vitreoretinal Diseases by Cluster Analysis.

Authors:  Tomomi Shitama; Hideyuki Hayashi; Sumiyo Noge; Eiichi Uchio; Kenji Oshima; Hisao Haniu; Nobuaki Takemori; Naoka Komori; Hiroyuki Matsumoto
Journal:  Proteomics Clin Appl       Date:  2008-09       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.